Condition: Relapsing Multiple SclerosisInterventions: Other: ofatumumab; Other: glatiramer acetate; Other: interferon β1Sponsor: Novartis PharmaceuticalsRecruiting Author:
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Condition: Multiple SclerosisInterventions: Drug: Pioglitazone; Drug: clemastine fumarate; Drug: Dantrolene; Drug: PirfenidoneSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting Author:
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Drug: AnakinraSponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author:
Tolebrutinib, a Brain-penetrant Bruton s Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: tolebrutinib 60mg; Drug: tolebrutinib 120mgSponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author:
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Condition: Relapsing Multiple SclerosisInterventions: Drug: Remibrutinib; Drug: TeriflunomideSponsor: Novartis PharmaceuticalsRecruiting Author:
Fatigue and Sleep Quality in Multiple Sclerosis Patients
Condition: Multiple SclerosisIntervention: Other: ReikiSponsor: Istanbul Sabahattin Zaim UniversityRecruiting Author:
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Condition: Progressive Multiple SclerosisInterventions: Drug: Placebo; Drug: Masitinib (4.5)Sponsor: AB ScienceRecruiting Author:
Lower Extremities Closed Kinetic Chain Training for People With MS
Condition: Multiple SclerosisIntervention: Combination Product: Telko plus conventional physical therapy (CPT)Sponsor: Anas Radi Hassan AlashramRecruiting Author:
Proof-of-concept Study for SAR441344 in Relapsing Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: SAR441344 IV; Drug: placebo IV; Drug: SAR441344 SC; Drug: placebo SC; Drug: MRI contrast-enhancing preparationsSponsor: SanofiActive, not recruiting Author:
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: Teriflunomide; Drug: PlaceboSponsor: Genzyme, a Sanofi CompanyActive, not recruiting Author:
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis
Condition: Multiple Sclerosis (MS)Interventions: Drug: Ocrelizumab; Drug: rHuPH20Sponsor: Hoffmann-La RocheActive, not recruiting Author:
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple SclerosisInterventions: Drug: Interferon beta-1a; Drug: Ocrelizumab-matching placebo; Drug: Ocrelizumab; Drug: Interferon beta-1a-matching placeboSponsor: Hoffmann-La RocheActive, not recruiting Author: